Cooperative Agreement U19AI181588

Award Date 5/15/24
Completion Date 4/30/29
Dollars Obligated $1.6M
Federal Grant Program
93.855
Assistance Type
Cooperative Agreement
Place of Performance
Malawi

The Kamuzu University of Health Sciences in Malawi was awarded a $1,600,540 Cooperative Agreement from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) to conduct a multi-year research program focused on accelerating malaria prevention in Malawi.

The key products and services to be delivered under this award include:

  • Evaluating the impact of the RTS,S malaria vaccine and new dual-insecticide bed nets on reducing the epidemiology of uncomplicated clinical malaria, Plasmodium falciparum infection, and malaria transmission
  • Assessing the long-term impact of the RTS,S vaccine on the incidence and age distribution of severe malaria
  • Analyzing Anopheles mosquito abundance, outdoor/early biting behaviors, and the potential impact of a novel transmission-blocking compound on malaria infection
  • Conducting multi-factorial investigations across 36 sites in 7 districts of southern Malawi to understand the complex ecological, entomological, and parasitological factors driving persistent malaria transmission in the region.

The research will leverage the Kamuzu University's existing capacity for long-term epidemiological surveillance and cross-disciplinary collaboration with U.S. and international partners.

Generated 3/4/25, 5:27 AM